Metabolic reprogramming in cancer cells: glycolysis, glutaminolysis, and Bcl-2 proteins as novel therapeutic targets for cancer
about
Dysfunctional BMPR2 signaling drives an abnormal endothelial requirement for glutamine in pulmonary arterial hypertensionImpact of Metabolism on T-Cell Differentiation and Function and Cross Talk with Tumor Microenvironment.Inhibition of stress-inducible HSP70 impairs mitochondrial proteostasis and function.Exosome-derived microRNAs in cancer metabolism: possible implications in cancer diagnostics and therapy.Metabolic profiling of zebrafish (Danio rerio) embryos by NMR spectroscopy reveals multifaceted toxicity of β-methylamino-L-alanine (BMAA).Santamarine Inhibits NF-κB Activation and Induces Mitochondrial Apoptosis in A549 Lung Adenocarcinoma Cells via Oxidative Stress.Simultaneous application of cisplatin and static magnetic field enhances oxidative stress in HeLa cell line.Molecular Determinants of Malignant Brain Cancers: From Intracellular Alterations to Invasion Mediated by Extracellular Vesicles.Glucose insult elicits hyperactivation of cancer stem cells through miR-424-cdc42-prdm14 signalling axis.Collateral Damage Intended-Cancer-Associated Fibroblasts and Vasculature Are Potential Targets in Cancer Therapy.Validity and clinical impact of glucose transporter 1 expression in colorectal cancer.Overexpression of miR-202 re-sensitizes imatinib resistant chronic myeloid leukemia cells through targeting Hexokinase 2 (HK2).Inhibition of Glycolysis and Glutaminolysis: Emerging Drug Discovery Approach to Combat Cancer.Tazarotene-Induced Gene 1 Interacts with DNAJC8 and Regulates Glycolysis in Cervical Cancer Cells.
P2860
Q33738642-BF483DA4-A19D-4549-91F6-B98DC5F9F342Q37694431-13D4C38B-FD0B-4A7A-BD60-63BFDA324C62Q38796931-48FECB31-02C7-462C-B06F-EB11DE00CB86Q39095744-54A531B9-C1F2-4503-9C55-0F740EAEFFD8Q46243379-66C63BA1-1432-4EF1-AB6C-62621F1FFF0AQ46265201-EA5A5BBD-9838-4F7D-A419-4ABD71A1BB75Q46302930-97F28974-D8B8-4147-AA78-C0396F52D5FBQ47183915-1BB2431C-FB6A-486F-AE6C-3F2F473C5BF3Q47661318-4113C605-C437-4DF7-9402-E21B0B19BFFCQ48049656-C9F9ABCC-2B28-4271-9FB8-1C86C215061CQ50074585-C826CC88-006B-4E06-BEAF-543B14F42FA1Q52646158-F921633A-1F72-4AD3-8D3F-91BD14EAADE9Q54978523-045EBB2D-CEEE-4AD9-9BDC-7371932FF97EQ55502534-25366B9A-46D9-416B-97C4-05FA70D31BE4
P2860
Metabolic reprogramming in cancer cells: glycolysis, glutaminolysis, and Bcl-2 proteins as novel therapeutic targets for cancer
description
2016 nî lūn-bûn
@nan
2016 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
name
Metabolic reprogramming in can ...... therapeutic targets for cancer
@ast
Metabolic reprogramming in can ...... therapeutic targets for cancer
@en
Metabolic reprogramming in can ...... therapeutic targets for cancer
@nl
type
label
Metabolic reprogramming in can ...... therapeutic targets for cancer
@ast
Metabolic reprogramming in can ...... therapeutic targets for cancer
@en
Metabolic reprogramming in can ...... therapeutic targets for cancer
@nl
prefLabel
Metabolic reprogramming in can ...... therapeutic targets for cancer
@ast
Metabolic reprogramming in can ...... therapeutic targets for cancer
@en
Metabolic reprogramming in can ...... therapeutic targets for cancer
@nl
P2093
P2860
P921
P1476
Metabolic reprogramming in can ...... therapeutic targets for cancer
@en
P2093
Chunxia Li
Guifeng Zhang
Hongbing Chen
P2860
P2888
P356
10.1186/S12957-016-0769-9
P407
P5008
P577
2016-01-20T00:00:00Z
P5875
P6179
1037330373